Edition:
United States

People: Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

27.30USD
28 Apr 2017
Change (% chg)

$0.55 (+2.06%)
Prev Close
$26.75
Open
$26.75
Day's High
$27.42
Day's Low
$26.55
Volume
340,804
Avg. Vol
251,150
52-wk High
$29.40
52-wk Low
$10.87

Strobeck, Matthew 

Dr. Matthew W. Strobeck, Ph.D. is Independent Director of Accelerate Diagnostics Inc. since July 7, 2012. Dr. Strobeck is currently the Managing Partner of Birchview Capital. Dr. Strobeck was a Partner and Member of the Management Committee and Advisory Board of Westfield Capital Management from 2008 until 2011, having served as a member of the investment team, specializing in healthcare and life sciences, from May 2003 to June 2008. Dr. Strobeck received his B.S. from St. Lawrence University, a Ph.D. from the University of Cincinnati, a S.M. from the Harvard University/MIT Health Sciences Technology Program, and a S.M. from the MIT Sloan School of Management.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 79,519
Fiscal Year Total, USD 79,519

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --